The Enterprise Value as of September 2024 (TTM) for Tyra Biosciences, Inc. (TYRA) is 966.91M

According to Tyra Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 966.91M. This represents a change of 56.03% compared to the average of 619.69M of the last 4 quarters.

Tyra Biosciences, Inc. (TYRA) Historical Enterprise Value (quarterly & annually)

How has TYRA Enterprise Value performed in the past?

The mean historical Enterprise Value of Tyra Biosciences, Inc. over the last ten years is 617.73M. The current 966.91M Enterprise Value has changed 15.55% with respect to the historical average. Over the past ten years (40 quarters), TYRA's Enterprise Value was at its highest in in the June 2024 quarter at 920.70M. The Enterprise Value was at its lowest in in the September 2021 quarter at -150456187.23.

Tyra Biosciences, Inc. (TYRA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tyra Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tyra Biosciences, Inc. (TYRA) Average Enterprise Value

How has TYRA Enterprise Value performed in the past?

The current Enterprise Value of Tyra Biosciences, Inc. (TYRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tyra Biosciences, Inc. (TYRA) Enterprise Value vs. Peers

How is TYRA’s Enterprise Value compared to its peers?

Tyra Biosciences, Inc.’s Enterprise Value is greater than Connect Biopharma Holdings Limited (-39789702.00), greater than RAPT Therapeutics, Inc. (36.36M), greater than Xilio Therapeutics, Inc. (-29408442.00), greater than Mineralys Therapeutics, Inc. (509.22M), less than Gracell Biotechnologies Inc. (5.46B), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Design Therapeutics, Inc. (272.10M), greater than Erasca, Inc. (667.94M), greater than Werewolf Therapeutics, Inc. (-5978336.00), greater than Ikena Oncology, Inc. (47.83M), greater than Stoke Therapeutics, Inc. (584.62M), greater than PMV Pharmaceuticals, Inc. (41.69M), greater than Pharvaris N.V. (679.28M), greater than Molecular Partners AG (-9800263.29), greater than Century Therapeutics, Inc. (149.62M), less than Edgewise Therapeutics, Inc. (1.54B), greater than C4 Therapeutics, Inc. (433.51M), greater than Cullinan Oncology, Inc. (866.65M),

Build a custom stock screener for Tyra Biosciences, Inc. (TYRA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tyra Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tyra Biosciences, Inc. (TYRA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tyra Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.